Product Details
Cefotetan Injection powder for solution
1g/2g
Product Description :
CEFOTETAN INJECTION 1 g / 2 g
Sterile Powder for Solution for Intravenous or Intramuscular Administration
1. COMPOSITION
Each vial contains:
• Cefotetan Disodium equivalent to Cefotetan 1 g / 2 g.
• Excipients: As applicable.
2. PHARMACEUTICAL FORM
Sterile, white to off-white powder for solution for intravenous or intramuscular administration.
3. THERAPEUTIC CLASS
Second-Generation Cephalosporin Antibiotic.
4. INDICATIONS
Cefotetan Injection is indicated for the treatment of susceptible bacterial infections, including:
• Intra-abdominal infections.
• Gynecological and pelvic infections.
• Urinary tract infections.
• Lower respiratory tract infections.
• Skin and soft-tissue infections.
• Bone and joint infections.
• Septicemia and other serious bacterial infections.
• Perioperative antimicrobial prophylaxis where clinically appropriate.
Treatment should be guided by the susceptibility of the causative organism and applicable antimicrobial guidelines.
5. CONTRAINDICATIONS
• Hypersensitivity to cefotetan, cephalosporins, or any component of the formulation.
• History of severe immediate hypersensitivity reactions to beta-lactam antibiotics.
6. DRUG INTERACTIONS
• Alcohol-containing beverages or preparations may cause a disulfiram-like reaction with cefotetan.
• Anticoagulants may increase the risk of bleeding and may require appropriate monitoring.
• Concomitant nephrotoxic medicines may increase the risk of renal toxicity.
• Probenecid may affect renal elimination of cefotetan.
The treating physician should review all concomitant medications before administration.
7. ADMINISTRATION
For intravenous or intramuscular administration after reconstitution with a compatible diluent under aseptic conditions. Administer according to the approved product information and institutional protocol.
8. STORAGE
Store according to the storage conditions stated on the approved product label. Protect from excessive heat, moisture and light. After reconstitution, use within the period specified in the approved product information. Do not use if the reconstituted solution shows visible particles, precipitation or unexpected discoloration.